Sponsors play a crucial role in Alcoholics Anonymous and Narcotics Anonymous. Why not create a similar support mechanism – “vaping sponsors” – to help people quit smoking?
Ignorance regarding pharmaceuticals is hardly bliss: even price control threats reliably chase essential investors away from risky drug development.
While independent research and collaborative data sharing have both proven to be effective methods of R&D, both have their drawbacks. Therefore, it is important for us to balance these two styles, so that we may maximize our results and provide logical, original answers to our most pressing concerns.
Medicaid has deviated from its original purpose of providing low-income Americans with good healthcare. A more focused approach to delivering Medicaid benefits would help fix a program that has failed for decades.
Now is the time for the GOP candidates to begin countering Obamacare and Hillarycare with plans of their own.
The real reason that Mrs. Clinton’s rhetorical stratagem will sell is that ObamaCare has left many consumers badly insured for “specialty” drug costs.
As we contemplate the future of genomics, and of precision medicine, it’s easy to get caught up in the technologies, in all the amazing gadgets and devices that we hear about every day. Yet, we must remember that while the promise of precision medicine may reflect advances in technology, realization of this potential will require impassioned champions.
I stand by the arguments in my WSJ op-ed: even the threat of price controls spooks investors and upsets the fragile ecosystem of medical innovation.
In the United States there is a market based pricing system for prescription drugs. Pharmaceutical companies set drug prices within some constraints. The rise in price for some prescription drugs has met a great deal of public backlash, especially Daraprim, which increased from $13.50 per tablet to $750 overnight.
Obamacare tried to re-engineer the rules of medical care and health insurance. Instead, the legislation only served to raise costs, and shrink the choices people have.